ADVERTISEMENT
ADVERTISEMENT
Abstract blue nautilus shell displaying a characteristic fractal shape
Attacking Cancer Targets with Radiotherapeutics
John Babich from Ratio Therapeutics explains how radiopharmaceuticals can be designed to better treat cancer, alone and in combination with immunotherapies.
Attacking Cancer Targets with Radiotherapeutics
Attacking Cancer Targets with Radiotherapeutics

John Babich from Ratio Therapeutics explains how radiopharmaceuticals can be designed to better treat cancer, alone and in combination with immunotherapies.

John Babich from Ratio Therapeutics explains how radiopharmaceuticals can be designed to better treat cancer, alone and in combination with immunotherapies.

Drug Discovery & Development

Green Bio-Rad Logo
Bio-Rad Extends Range of Foresight Pro Prepacked Chromatography Columns for Biotherapeutic Production
Bio-Rad Laboratories | Jan 7, 2025 | 2 min read
Foresight Pro 45 cm ID Column Provides a Convenient and Reliable Solution for Purification of Biomolecules in Downstream Bioprocessing.
Advances in Cancer Therapies and Diagnostics
Advances in Cancer Therapies and Diagnostics
The Scientist Staff | Jan 6, 2025 | 2 min read
Learn about the latest research in cancer biology and translational applications.
An illustration of an orange tau fibril in front of a blue background.
Uncovering the Unexpected: Developing a Novel Anti-Tau Therapy
Charlene Lancaster, PhD | Dec 31, 2024 | 4 min read
Ke Hou generated a compound that prevents tau aggregation in the murine brain, but the potential Alzheimer’s disease therapy also had a surprising property.
Gram-negative, rod-shaped bacteria expressing pili.
Building Bacterial Drug Factories
Aparna Nathan, PhD | Dec 30, 2024 | 3 min read
Drug-manufacturing bacteria can provide a more targeted approach to treat gut diseases.
A man holds his knee and grimaces in pain while sitting in front of a bridge.
A Nanoparticle Approach to Treat Torn Tendons
Aparna Nathan, PhD | Dec 29, 2024 | 4 min read
Alayna Loiselle has found a way to bring therapeutics straight to an injured tendon.
Graphic depicting a tumor being targeted by a drug
Great Anticancer Potential Comes in a Small Package 
Niki Spahich, PhD | Dec 28, 2024 | 4 min read
Jingjing Sun developed a novel, ultra-small nanocarrier that actively targets tumor cells.
A conceptual illustration of scientists evaluating potential kinase inhibitors.
Leveraging Recombinant Kinases for Drug Discovery Research
The Scientist and Sino Biological | Dec 26, 2024 | 3 min read
As kinase dysfunction underlies many pathological conditions, scientists require high-quality active kinases for their therapeutic development programs.
3D conceptual image of antibodies on a blue background.
Improving the Efficiency and Reliability of Fully Human Antibody Drug Development
The Scientist Staff | Dec 16, 2024 | 2 min read
Microfluidic technology enables high-throughput, droplet-based antibody discovery in fully human antibody mice.
Brightfield microscopy image of Aspergillus fumigatus.
The Silent Pandemic of Antifungal Resistance
Danielle Gerhard, PhD | Dec 16, 2024 | 2 min read
As the world grapples with antimicrobial-resistant bacteria, another insidious threat looms large: drug-resistant fungi.
New Frontiers in Vaccine Development
New Frontiers in Vaccine Development
The Scientist Staff | Dec 12, 2024 | 2 min read
Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.
Evotec logo
Evotec SE announces first projects for LAB eN² drug discovery accelerator with Novo Nordisk
Evotec | Dec 11, 2024 | 3 min read
Novo Nordisk and Evotec select three projects from Boston University, Harvard University in collaboration with Mass General Brigham, and Joslin Diabetes Center to be developed within LAB eN² focusing on cardiometabolic diseases
Beckman logo
Beckman Coulter Life Sciences Accelerates Drug Discovery with Launch of Cydem VT Automated Clone Screening System
Beckman Coulter Life Sciences | Dec 4, 2024 | 2 min read
High-Throughput Platform Reduces Manual Steps by up to 90%
Scientist at lab bench holding a pipette with a microscope and glassware in the foreground.
Improving Drug Analysis with Supercritical Fluid Chromatography
Shimadzu | Dec 2, 2024 | 1 min read
Researchers easily separate chiral and achiral compounds for drug analysis and purification.
A photo of a 96-well microplate showcasing serial dilutions of purple dye solution.
Achieving Consistency in Serial Dilutions
The Scientist Staff | Dec 2, 2024 | 2 min read
Researchers ensure the success of their serial dilution-based assays by using optimized protocols and advanced liquid handling tools.
An illustration of mRNA molecules.
Probing the Structure of mRNA Molecules
Shimadzu | Nov 25, 2024 | 1 min read
Learn how scientists examine mRNA quality using an easy-to-operate LC-MS system.
Drugging the Undruggable
Drugging the Undruggable
The Scientist Staff | Nov 19, 2024 | 1 min read
Learn how cutting-edge strategies empower researchers to target undruggable proteins.
Takara Bio Logo
Takara Bio launches high-throughput, cost-effective qPCR system to advance clinical research
Takara Bio | Nov 19, 2024 | 2 min read
The SmartChip ND system meets laboratories’ needs for flexibility, scalability, efficiency, and affordability.
A cartoon of pills and bacteria along the human intestine.
An Antibiotic That Distinguishes Friend from Foe
Sneha Khedkar | Nov 19, 2024 | 4 min read
A novel compound targets an essential transport system found only in disease-causing bacteria, leaving commensal bacteria unharmed. 
Nathalie Fuentes, a senior scientist at AstraZeneca, is shown completing two of her roles: on the left, she prepares regulatory paperwork for a new drug, while on the right, she documents information from stability testing a new drug.
The Secrets of Securing a Senior Scientist Role in an Industry
Shelby Bradford, PhD | Nov 15, 2024 | 5 min read
Nathalie Fuentes shared her experience of landing a unicorn position in a pharmaceutical company after a postdoctoral fellowship.
ADVERTISEMENT